Norway· NO-ID_70C4CA7D-1D90-4023-9E6E-2DAB2DFD729F

Relifex

A nabumetone product containing nabumetone, registered in Norway by Viatris AS. The same ATC class is registered in 14 of our 19 countries.

ATC M01AX01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedRelifexATCM01AX01REGISTER NO.NO-ID_70C4CA7D-1D90-4…PACKS LISTED3CHECKEDSeptember 11, 2026

Where it is registered

Nabumetone is registered in 14 of 19 countries.

Countries holding a registration under ATC M01AX01 (nabumetone), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose

Nabumetone · ATC M01AX01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nabumetone costs, country by country.

Normalised to the WHO defined daily dose (1 g), the median price runs from $0.37 in France to $0.73 in Italy — a ×2.0 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Nabumetone · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • IT Italy$0.73
  • FR France$0.37
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Nabumetone
Manufacturer
Viatris AS
Country
Norway (NO)
ATC code
M01AX01
ATC class
Nabumetone
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 11, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_70C4CA7D-1D90-4023-9E6E-2DAB2DFD729F
  • no_varenummer
    551606
    100
    NOK 156.2
  • gtin
    7046265516064

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

289 interactions on record for nabumetone.

Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Nabumetone · interactions on record

289 records

  • 57 severe
  • 142 moderate
  • 4 minor
  • 86 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nabumetone in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nabumetone products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Belgium · Gambaran, Nabumeton Tillomed
  • Germany · Relifex
  • Estonia · Relifex
  • Spain · Relif
  • France · Nabucom
  • United Kingdom (Northern Ireland) · Nabumetone Accord-Uk, Nabumetone Kent Pharma Uk
  • Greece · Akratol, Nabuton
  • Hungary · Relifex
  • Ireland · Nabumetone Tillomed, Relifex
  • Iceland · Relifex
  • Italy · Nabuser
  • Lithuania · Relifex
  • Luxembourg · Gambaran
  • Latvia · Relifex
  • Netherlands · Mebutan, Mebutan Dispers
  • Poland · Nabuton Vp
  • Sweden · Relifex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/885062aa-1cb3-410e-a096-d91aeeed0552
GET /v1/drugs/885062aa-1cb3-410e-a096-d91aeeed0552?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett, filmdrasjert",
  "source": "fest",
  "status": "A",
  "atc_name": "Nabumeton",
  "merkevare_id": "ID_70C4CA7D-1D90-4023-9E6E-2DAB2DFD729F",
  "name_form_strength": "Relifex tab 500 mg",
  "prescription_group": "C"
}

See everything about nabumetone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.